Examining 2021 Prospects for the Notorious ARKK ETF

It’s now the largest actively managed exchange traded of any variety, and its one of the best-performing ETFs this year, active or passive. The ARK Innovation ETF ( ARKK ) didn’t get here by chance. ARKK is often highlighted for being an early ETF advocate for Tesla ( NASDAQ : TSLA ). The case for Tesla upside remains strong because of continuous advancements in EV. “Electric vehicles may cost about the same as their gas-guzzling brethren in just three or four years — and only get cheaper from there,” reports David Baker for Bloomberg .

Continue reading

DGRW: Pfizer’s Vaccine News Could Set This ETF Into Motion

The WisdomTree U.S. Quality Dividend Growth ETF ( DGRW ) focuses on the dividend growth & quality factors and could be uniquely positioned to outperform in a post-vaccine world Positioning For The Re-Opening Rally The news of Pfizer’s potential coronavirus vaccine yielding very encouraging results in the early findings of its clinical trial was more than enough to send investors racing into risk assets betting that a full economic recovery could be on the way.
Instead, DGRW looks at long-term earnings growth expectations as a proxy for a company’s ability to continue paying and growing its dividend over time.

Continue reading

bunch of white oval medication tablets and white medication capsules

Inside a Star Genomics ETF’s Notoriety

ARKG includes companies that merge healthcare with technology to capitalize on the revolution in genomic sequencing.
“CRISPR’s addressable market in the monogenic disease space could scale to $75B annually with nearly $2T in latent demand from unaddressed populations.

Continue reading

1 19 20 21